First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
Related Posts
Medrano L, Bursch B, Weiss JE, Jackson N, McCurdy D, Hoftman A. Medical Post-Traumatic Stress Disorder Symptoms in Children and Adolescents with Chronic Inflammatory Arthritis:[...]
Hynes CA, Hau C, Woods P, Leatherman S, Anand ST, Glassman P, Taylor A, Cushman WC, Ishani A, Ferguson R. Medication Adherence in the Real[...]
Liu X, Baecker A, Wu M, Zhou J, Jin Z, Mu L, He N, Rao J, Lu QY, Li L, Zhao JK, Zhang ZF. Tea[...]